Born in Mumbai, Reshma moved to the United States in 1988. She pursued a career in medicine, earning her degree from Boston ...

Among key findings, 2022 emerged as a standout year with a record USD 749 million invested—nearly 40% of the five-year total. However, funding saw a dip to USD 269 million in 2024, indicating a ...

The India BioEconomy Report, released by the Department of Biotechnology, says there is ample opportunity for this sector to grow to about $300 billion by 2030, and to $1 trillion by 2047.

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

If India is looking at China for inspiration in the startup ecosystem, then it would be remiss not to also examine China’s strides in the biotechnology sector. The potential for growth and ...

India, co-leading the Mission Integrated Biorefinery alongside the Netherlands under Mission Innovation 2.0, showcased its ...

Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...

HYDERABAD, March 20 (Reuters) - Indian vaccine maker Bharat Biotech said on Thursday it had invested $75 million in its first cell and gene therapy (CGT) facility in the southern Indian state of ...

India's drug regulator, CDSCO, has ordered a halt to the production, sale, and distribution of 35 fixed-dose combination (FDC ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of India's only vertically integrated, purpose ...